IPCA Laboratories - Progressing Steadily to Reclaim the Growth Path
Domestic formulation (DF) is the key driver of its sales growth, fueled by market outperformance in pain/dermatology/urology and supported by...
440 Views
Ipca Laboratories - Domestic Business Stable but Exports Volatile…
pca is a fully integrated pharma company manufacturing over 350 formulations and 80 APIs with exports contributing 50% of revenues in FY21.
273 Views
Ipca Laboratories - Domestic Business Stable but Exports Volatile
Ipca is a fully integrated pharma company manufacturing over 350 formulations and 80 APIs with exports contributing 50% of revenues in FY21.
392 Views
Ipca Laboratories (IPCLAB) - Domestic Business Stable but Exports Volatile…
Ipca is a fully integrated pharma company manufacturing over 350 formulations and 80 APIs with exports contributing 50% of revenues in FY21.
355 Views
Ipca Laboratories - On Course to Revive Earnings Growth
The domestic formulation (DF) segment continues on its robust growth path, led by market share gain, favorable price hikes, addition of medical...
333 Views